沸点	154-155 ºC
闪点	93 ºF
密度	0.922
折射率	1.436

危险类别码	R10
安全说明书	S16;S29;S33

来源	SDS样本
Sigma-Aldrich	浏览或下载
TCI	浏览或下载
Apollo	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Enhancement of sensitivity to platinum(II)-containing drugs by 12-O-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line.S Isonishi et al.British journal of cancer, 69(2), 217-221 (1994-02-01) An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells.V Murray et al.Biochemistry, 31(47), 11812-11817 (1992-12-01) Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line.R Jamshidipour et al.Cancer chemotherapy and pharmacology, 34(6), 484-490 (1994-01-01) Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro.A P Jekunen et al.Biochemical pharmacology, 45(10), 2079-2085 (1993-05-25) Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.G R Gibbons et al.Carcinogenesis, 12(12), 2253-2257 (1991-12-01) Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships.P Mailliet et al.Anti-cancer drug design, 10(1), 51-73 (1995-01-01) Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cells.P Naredi et al.The Journal of clinical investigation, 95(3), 1193-1198 (1995-03-01) An experimental and theoretical investigation into the hydrolysis of dichloro(ethylenediamine)platinum(II) via electrospray mass spectrometry and density functional theory.Akihiko Yoshikawa et al.Journal of the American Society for Mass Spectrometry, 20(6), 1015-1029 (2009-03-17) Analysis and quantitation of the DNA damage produced in cells by the cisplatin analog cis-[3H]dichloro(ethylenediamine)platinum (II).A Eastman Analytical biochemistry, 197(2), 311-315 (1991-09-02) cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro.R J Holmes et al.Journal of inorganic biochemistry, 85(2-3), 209-217 (2001-06-19) Role of carrier ligand in platinum resistance in L1210 cells.G R Gibbons et al.Cancer research, 50(20), 6497-6501 (1990-10-15) Sequence specificity and reactivity of the binding of phenazine-tethered platinum complexes to DNA.L C Perrin et al.Anti-cancer drug design, 14(3), 243-252 (1999-09-29) Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.V M Richon et al.Cancer research, 47(8), 2056-2061 (1987-04-15) Inhibition of immunopurified DNA polymerase-alpha from PA-3 prostate tumor cells by platinum (II) antitumor drugs.T J Kelley et al.Cancer biochemistry biophysics, 13(3), 135-146 (1993-06-01) Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes.A Eastman Chemico-biological interactions, 61(3), 241-248 (1987-03-01) Platinum complexes with binding affinity for the estrogen receptor.N Knebel et al.Journal of medicinal chemistry, 31(9), 1675-1679 (1988-09-01) Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.A Basu et al.Cancer research, 52(11), 3119-3124 (1992-06-01) Steric control of stereoselective interactions between the platinum(II) complex [PtCl2(1,4-diazacycloheptane)] and DNA: comparison with cis-[PtCl2(NH3)2] and [PtCl2(ethane-1,2-diamine)] using DNA binding and molecular modeling studies.T W Hambley et al.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 6(5-6), 534-542 (2001-07-27) [Antiviral action of the macromolecular derivative of the platinum with deoxyribonucleic acid in the treatment of patient with malignant liver neoplasm].S A Shalimov et al.Klinicheskaia khirurgiia, (8)(8), 36-38 (1994-01-01) Coordination chemistry in biological media: reactions of antitumor Pt(II) and Au(III) complexes with cell culture media.J D Bell et al.Journal of inorganic biochemistry, 31(4), 241-246 (1987-12-01) Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cells.A P Jekunen et al.Cancer research, 54(10), 2680-2687 (1994-05-15) Inactivation of dihydropteridine reductase (human brain) by platinum(II) complexes.W L Armarego et al.European journal of biochemistry, 164(2), 403-409 (1987-04-15) Modulation of platinum antitumor drug binding to DNA by linked and free intercalators.B E Bowler et al.Biochemistry, 25(10), 3031-3038 (1986-05-20) Carrier mediated action of platinum complexes on estrogen receptor positive tumors.N Knebel et al.European journal of cancer & clinical oncology, 25(2), 293-299 (1989-02-01) Analysis of the cytotoxic interaction between cisplatin and hyperthermia in a human ovarian carcinoma cell line.E Kimura et al.Cancer chemotherapy and pharmacology, 32(6), 419-424 (1993-01-01)

备注